Since the company registration one hundred and nineteen events have happened. The last three records are Confirmation statement made on 29 October 2016 with updates; Total exemption small company accounts made up to 31 December 2015; Annual return made up to 29 October 2015 with full list of shareholders Statement of capital on 2015-11-18 GBP 181,915.93 . The most likely internet sites of OXFORD DRUG DESIGN LIMITED are www.oxforddrugdesign.co.uk, and www.oxford-drug-design.co.uk. The predicted number of employees is 1 to 10. The company’s age is twenty-four years and four months. The distance to to Battersea Park Rail Station is 3.5 miles; to Brondesbury Park Rail Station is 5.5 miles; to Beckenham Hill Rail Station is 6.8 miles; to Bickley Rail Station is 9.7 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Oxford Drug Design Limited is a Private Limited Company. The company registration number is 04305857. Oxford Drug Design Limited has been working since 17 October 2001. The present status of the company is Active. The registered address of Oxford Drug Design Limited is The Walbrook Building 25 Walbrook London England Ec4n 8af. . IP2IPO SERVICES LIMITED is a Secretary of the company. FINN, Paul William is a Director of the company. RICHARDS, William Graham, Professor is a Director of the company. IP2IPO SERVICES LIMITED is a Director of the company. Secretary DAVIES, John Quantrill has been resigned. Secretary PARISH, James Maxwell has been resigned. Secretary WCPHD SECRETARIES LIMITED has been resigned. Director ASKEW, Herbert Frank, Dr. has been resigned. Director DAVIE, Paul Jonathan has been resigned. Director DAVIES, John Quantrill has been resigned. Director MOSES, Edwin, Dr has been resigned. Director NAYLOR, Andrew James has been resigned. Director NORWOOD, David Robert has been resigned. Director PORTER, Barry, Dr has been resigned. Director WESTERGREN, Jussi Pekka has been resigned. Director WCPHD DIRECTORS LIMITED has been resigned. The company operates in "Research and experimental development on biotechnology".